Children included in randomised controlled trials of biologics in inflammatory bowel diseases do not represent the real‐world patient mix

BACKGROUND: Patients enrolled in randomised controlled trials (RCTs) may differ from the target population due to restricted eligibility criteria. AIM: To compare treatment response to biologics in routine practice for children with inflammatory bowel diseases (IBD) who would and would not have been...

Descripción completa

Detalles Bibliográficos
Autores principales: Atia, Ohad, Pujol‐Muncunill, Gemma, Navas‐López, Víctor Manuel, Orlanski‐Meyer, Esther, Ledder, Oren, Lev‐Tzion, Raffi, Focht, Gili, Shteyer, Eyal, Stein, Ronen, Aloi, Marina, Russell, Richard K., Martin‐de‐Carpi, Javier, Turner, Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
PAEDIATRIC SUBJECTS IN RCTs OF BIOLOGICS IN IBD
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542175/
https://www.ncbi.nlm.nih.gov/pubmed/35735987
http://dx.doi.org/10.1111/apt.17092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542175/
https://www.ncbi.nlm.nih.gov/pubmed/35735987
http://dx.doi.org/10.1111/apt.17092

Ejemplares similares